What is Forbion?
Forbion operates as a leading European venture capital firm, specializing in bridging the gap between research and development in the life sciences sector. The firm leverages its deep expertise in drug development and company building to identify and nurture promising ventures. Forbion's commitment to responsible investment is further highlighted by its signatory status to the United Nations Principles for Responsible Investment, emphasizing a philosophy where investments are intended to positively impact patient health and well-being.
How much funding has Forbion raised?
Forbion has raised a total of $2.2B across 1 funding round:
Unspecified
$2.2B
Unspecified (2024): $2.2B, investors not publicly disclosed
What's next for Forbion?
With substantial enterprise-level funding and a recent strategic investment, Forbion is well-positioned to accelerate its investment activities and expand its portfolio. The firm's focus on drug development and patient-centric healthcare innovations suggests a strategic direction towards supporting companies that address critical unmet medical needs. This capital infusion will likely enable Forbion to deepen its engagement with portfolio companies, providing critical support for their R&D pipelines and commercialization efforts, thereby reinforcing its role as a key player in European biotech and pharmaceutical investment.
See full Forbion company page
